Genomics science continues to play a major role in the generation of new knowledge in the basic research arena. How these learnings translate into product development also involves the integration of genomics data, including pharmacogenomics as well as “Big Data” into the regulatory decision-making process. This symposium will introduce and examine all of these topics in an interactive forum with an emphasis on innovation and translation.
Introduction
Eunjoo Pacifici, PharmD, PhD
USC, SC-CTSI, School of Pharmacy I Chair & Associate Professor, Dept. of Reg. & Quality Sciences Associate Director, DK Kim International Center for Regulatory Science
Genomics and Regulation
Nancy Pire-Smerkanich, DRSc
USC, SC-CTSI, School of Pharmacy I Assistant Professor, Dept. of Reg. & Quality Sciences
Novel Regulatory Science Paradigms Based on Data and Analytics
Klaus A. Romero Cepeda, MD, MS, FCP
C-Path Institute I Chief Science Officer & Executive Director, Clinical Pharmacology and Quantitative Medicine
Pharmacogenomics
Scott Mosley, PharmD
USC, School of Pharmacy I Assistant Professor of Titus Department of Clinical Pharmacy
Big Data and Genomics
Jerry SH Lee, PhD
USC, Keck School of Medicine & Viterbi School of Engineering I Associate Professor
USC, Lawrence J. Ellison Institute for Transformative Medicine I Chief Science and Innovation Officer
Applied Genomics and Target Identification
Robert Pacifici, PhD
CHDI Foundation I Chief Scientific Officer
Wrap-Up
Eunjoo Pacifici, PharmD, PhD
USC, SC-CTSI, School of Pharmacy I Chair & Associate Professor, Dept. of Reg. & Quality Sciences Associate Director, DK Kim lnternational Center for Regulatory Science